An injectable and active hydrogel induces mutually enhanced mild magnetic hyperthermia and ferroptosis

• Published in: Biomaterials Vol. 298; p. 122139
• Main Authors: Chen, Xiaobin, Wang, Hancheng, Shi, Jiayue, Chen, Zhiyong, Wang, Yaoben, Gu, Siyi, Fu, Ye, Huang, Jiale, Ding, Jiandong, Yu, Lin
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.07.2023
• Subjects: Animals; Cell Line, Tumor; Ferroptosis; Hydrogels; Hyperthermia, Induced - methods; Hysteresis loss; Magnetic hyperthermia therapy (MHT); Mice; Multiple hyperthermia; Nanoparticles; Neoplasms - therapy; Theranostics; Thermosensitive hydrogel; Hysteresis loss; Ferroptosis; Magnetic hyperthermia therapy (MHT); Theranostics; Thermosensitive hydrogel; Multiple hyperthermia
• DOI: 10.1016/j.biomaterials.2023.122139
• ISSN: 0142-9612; 1878-5905

Magnetic hyperthermia therapy (MHT) is a promising new modality to deal with solid tumors, yet the low magnetic-heat conversion efficacy, magnetic resonance imaging (MRI) artifacts, easy leakage of magnetic nanoparticles, and thermal resistance are the main obstacles to expand its clinical applications. Herein, a synergistic strategy based on a novel injectable magnetic and ferroptotic hydrogel is proposed to overcome these bottlenecks and boost the antitumor efficacy of MHT. The injectable hydrogel (AAGel) exhibiting a sol-gel transition upon heating is made of arachidonic acid (AA)-modified amphiphilic copolymers. Ferrimagnetic Zn0.4Fe2.6O4 nanocubes with high-efficiency hysteresis loss mechanism are synthesized and co-loaded into AAGel with RSL3, a potent ferroptotic inducer. This system maintains the temperature-responsive sol-gel transition, and provides the capacity of multiple MHT and achieves accurate heating after a single injection owing to the firm anchoring and uniform dispersion of nanocubes in the gel matrix. The high magnetic-heat conversion efficacy of nanocubes coupled with the application of echo limiting effect avoids the MRI artifacts during MHT. Besides the function of magnetic heating, Zn0.4Fe2.6O4 nanocubes combined with multiple MHT can sustain supply of redox-active iron to generate reactive oxygen species and lipid peroxides and accelerate the release of RLS3 from AAGel, thus enhancing the antitumor efficacy of ferroptosis. In turn, the reinforced ferroptosis can alleviate the MHT-triggered thermal resistance of tumors by impairment of the protective heat shock protein 70. The synergy strategy achieves the complete elimination of CT-26 tumors in mice without causing local tumor recurrence and other severe side effects.